MST Financial is delighted to welcome Professor Bruce Robinson as an adviser to MST’s expanding healthcare practice.

Professor Robinson is a distinguished clinician, academic and healthcare business leader, with deep expertise across biotechnology, medical research and commercialisation. He has held senior leadership roles in Australian health and medical research, including as Chair of the National Health and Medical Research Council (NHMRC), and is widely recognised as one of Australia’s leading figures in the sector.

Professor Robinson will provide advisory services primarily to MST’s capital-markets team, and their clients across biotechnology, medtech and related healthcare sectors. He will also be available to assist companies with advisory and institutional clients with assessment on the scientific, clinical and commercialisation relevant to healthcare investments.

The appointment of Professor Robinson demonstrates MST’s commitment to the healthcare sector, where MST retains a top-rated equities research team, led by Andrew Goodsall & Dan Hurren and supported by 3 experienced analysts.

We are pleased that Professor Robinson has agreed to work with MST and its clients to promote investment in Australia’s growing biotechnology, medtech and healthcare sector.